This session will present the mission and global efforts of the Oncidium Foundation to improve access to Targeted Radionuclide therapy (TRT) for people living with cancer, especially in underserved regions. It will showcase collaborations with partners, including the IAEA through the Rays of Hope program and key Belgian players such as IBA, IRE, Pantera & SCK-CEN for radiopharmaceuticals production, and the Jules Bordet Institute for clinical application. Special focus will be placed on expanding access to alpha-therapy. These joint efforts aim to bridge the gap between innovation and accessibility, ensuring that advanced cancer treatments reach those who need them. This event is organized by Belgium.

This event will be held on Tuesday, 16 September 2025, from 3.00 p.m. to 4.30 p.m. in Conference Room M6, M Building, ground floor.